1999
DOI: 10.1111/j.1749-6632.1999.tb07823.x
|View full text |Cite
|
Sign up to set email alerts
|

Functional Brain Imaging in the Resting State and during Activation in Alzheimer's Disease: Implications for Disease Mechanisms Involving Oxidative Phosphorylation

Abstract: In vivo brain imaging of patients with Alzheimer's disease (AD) using positron emission tomography (PET) demonstrates progressive reductions in resting-state brain glucose metabolism and blood flow in relation to dementia severity, more so in association than primary cortical regions. During cognitive or psychophysical stimulation, blood flow and metabolism in the affected regions can increase to the same extent in mildly demented AD patients as in age-matched controls, suggesting that energy delivery is not r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
26
1
2

Year Published

2002
2002
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(29 citation statements)
references
References 66 publications
0
26
1
2
Order By: Relevance
“…How can these observations be reconciled with our data showing increased astrocytic glucose metabolism? A current explanation for the decrease of glucose metabolism in AD is that glucose utilization by neural cells in the affected brain areas is impaired (Blass, 2001;Gibson, 2002), as supported by observations of deficient activity of some enzymes involved in energy metabolism in AD brain extracts (Rapoport, 1999;Blass et al, 2000;Liang et al, 2008). In contrast, other reports have described an increase in the activity of enzymes linked to glucose metabolism (Bigl et al, 1999;Soucek et al, 2003).…”
mentioning
confidence: 73%
“…How can these observations be reconciled with our data showing increased astrocytic glucose metabolism? A current explanation for the decrease of glucose metabolism in AD is that glucose utilization by neural cells in the affected brain areas is impaired (Blass, 2001;Gibson, 2002), as supported by observations of deficient activity of some enzymes involved in energy metabolism in AD brain extracts (Rapoport, 1999;Blass et al, 2000;Liang et al, 2008). In contrast, other reports have described an increase in the activity of enzymes linked to glucose metabolism (Bigl et al, 1999;Soucek et al, 2003).…”
mentioning
confidence: 73%
“…This is because of the large number of clinical conditions that are accompanied by disturbed coupling of neural activity and CBF/BOLD, e.g., migraine, stroke, and Alzheimer's disease (Olesen et al, 1981;Nelles et al, 1999;Rapoport, 1999). These findings can be reproduced in experimental disease models.…”
Section: Deactivationmentioning
confidence: 99%
“…18 F-2-fluoro-2-deoxy-D-glucose ( 18 FDG) is a tracer of cellular energy metabolism. It has been used extensively to monitor the metabolic activity of cells in vivo in the brain [2][3][4][5] and to detect tumours [6][7][8]. 18 FDG differs from glucose by the substitution of the hydroxyl group with a fluorine atom on the second carbon of the glucose.…”
mentioning
confidence: 99%